Teoxane SA develops and manufactures hyaluronic acid-based dermal fillers. It offers ageing process and solutions that include skin glow loss, correct wrinkles, and facial volume loss; derma fillers such as injections and Teosyal range; and skincare products. The company was founded by Valerie Taupin in 2003 and is headquartered in Geneva, Switzerland.

Orexa is a pharmaceutical company that provides therapeutics to increase food intake. Its main ingredient is a human-use oral formulation that is proprietary and based on a well-known anesthetic. The company's invention is based on several well-known anesthetics with a well-established safety profile. These anesthetics are typically administered by injection, but Orexa's research demonstrates that they can also be administered orally with a local mode of action.

Huzhou Enovix Pharmaceutical Co., Ltd., established on 2016-07-19, Business scope includes technical research and development of biopharmaceutical preparations,technology transfer,Technical Consulting and Technical Services.

EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY.

Part of Catalent, Inc., Columbia Laboratories (Bermuda) Ltd. is a Bermudian company located in Hamilton. The firm manufactures pharmaceutical products.

Shandong Chengchuang Pharmaceutical Technology Development Co., Ltd., established on 1999-08-06, Business scope includes pharmaceutical,chemical industry,New technology research and development of health care products,Technical achievement transfer and related technical consulting services;Realtor;property management;car park service;office services;Technology intermediary service;Information Technology Consulting Services;Intellectual property services and other legal,regulations,Items that are not prohibited by the State Council's decision and do not require a business license.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xi'an Libang Biomedical Technology Co., Ltd., established on 2017-04-27, The scope of business includes technology development in the field of biomedicine and chemical products,technical consulting,Technical Services,technology transfer;Biological product,medicine,Chinese patent medicine and raw materials,Pharmaceutical Intermediates,Diagnostic reagents,Technology development of medical devices;Chemical Products(non-hazardous,monitor,precursor chemicals),Equipment,metallic material,Sales of building materials;Import and export of goods and technology(country restrictions,Excluding goods and technologies that are prohibited and subject to approval for import and export);Equipment rental and maintenance. (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Ease Asset Management Ltd., TTI Ellebeau, Inc. is a Japanese company located in Tokyo that develops, manufactures, and distributes medicinal and quasi drugs. The firm was acquired by Ease Asset Management Ltd. from Pine Capital Group Ltd. on April 21, 2014.

Nagase Medicals Co., Ltd. engages in the development, manufacture, and sale of ethical drugs, medical devices, medical materials, and veterinary drugs. The company was founded on July 1, 1972 and is headquartered in Itami, Japan.

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others. The company was founded by Anmin Yamada on February 22, 1899 and is headquartered in Osaka, Japan.

Guangzhou Manxiang Pharmaceutical Co., Ltd., established on 2011-01-28, The scope of business includes the production of Class I medical devices;Information Technology Consulting Services;Conference and Exhibition Services;Engineering and Technology Research and Experimental Development;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Network technology service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Computer System Services;Health Consulting Services(Does not include medical services);Sales of Class I Medical Devices;Information Consulting Service(Not including licensing information consulting services);Etiquette service;Consulting and planning service;market survey(Does not include foreign investigations);marketing planning;Organize cultural and artistic exchange activities;advertisement making;Business Management Consulting;Medical equipment rental;synthetic material manufacturing(Free of Hazardous Chemicals);Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Sales of Class II Medical Devices;Production of Class III Medical Devices;Production of Class II Medical Devices;pharmaceutical production;Technology Import and Export;Import and export;Cosmetic production;advertising(radio station,television station,Newspaper Publishing Unit);medical service;Class III medical device business;Internet Information Service for Medical Devices

Shandong Chenlong Pharmaceutical Co., Ltd., established on 2012-10-26, Business scope includes research and development of biomedicine,production and sales;API R&D,production and sales(The operating permit,The scope of business is subject to the terms of the scope of the license);Research and development of pharmaceutical intermediates,production and sales;Self-operated and agent import and export business of the above commodities(Projects prohibited and restricted by the state shall not be operated,Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Shandong Anbida Pharmaceutical Co., Ltd., established on 2005-04-21, Business scope includes licensed projects:Drug retail;Class III medical device business;Drug Wholesale.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class II Medical Devices;Retailing of protective equipment for healthcare workers;Disinfectant sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;daily mask(non-medical)Sales;Production of protective equipment for medical personnel(Ι class medical device);Production of Class I Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)